close

  
Filter options:

Freebase Commons Metaweb System Types /type

Object is not asserted on this topic.
Key

Freebase Commons Common /common

Description
  • Genentech Inc. (NYSE:DNA), a composite of Genetic Engineering Technology, Inc., is a leading biotechnology corporation, which was founded in 1976 by venture capitalist Robert A. Swanson and biochemist Dr. Herbert W. Boyer. Considered the founder of the biotechnology industry, Genentech has been delivering on the promise of biotechnology for more than 30 years, using human genetic information to discover, develop, commercialize and manufacture biotherapeutics that address significant unmet medical needs. Today, Genentech is among the world's leading biotech companies, with multiple products on the market for serious or life-threatening medical conditions and over 50 projects in the pipeline. The company is the leading provider of anti-tumor therapeutics in the United States.
  • Genentech Inc., is a biotechnology corporation, founded in 1976 by venture capitalist Robert A. Swanson and biochemist Dr. Herbert Boyer. Boyer is considered to be a pioneer in the field of recombinant DNA technology. In 1973, Boyer and his colleague Stanley Norman Cohen demonstrated that restriction enzymes could be used as "scissors" to cut DNA fragments of interest from one source, to be ligated into a similarly cut plasmid vector. While Cohen returned to the laboratory in academia, Swanson contacted Boyer to found the company. Boyer worked with Arthur Riggs and Keiichi Itakura from the Beckman Research Institute, and the group became the first to successfully express a human gene in bacteria when they produced the hormone somatostatin in 1977. David Goeddel and Dennis Kleid were then added to the group, and contributed to its success with synthetic human insulin in 1978. As of August 2013, Genentech employed more than 12,300 people. The Swiss global health-care company F. Hoffmann-La Roche AG now completely owns Genentech after completing its purchase on March 26, 2009 for approximately $46.8 billion. Wikipedia

Freebase Commons Business /business

Freebase Commons Organization /organization

Street Address Street Address 2 Street Address 3 Street Address 4 City/Town State/Province/Region Postal Code Country
Country code Number Contact category Caller category Product or service Service language Service location Description Toll free Hearing impaired
  • (877) 436-3683
  • Patient Resource Center. Genentech's center dedicated to getting patients and caregivers to the right resource.
  • true
  • false
  • (866) 422-2377
  • Genentech Access Solutions. Provides coverage and reimbursement support, patient assistance and information resources.
  • true
  • false
  • (800) 530-3083
  • Genentech Access to Care Foundation. For eligible patients who are uninsured or who have been rendered uninsured because they have been denied coverage by their insurance company.
  • true
  • false
  • (800) 334-0290
  • -
  • Product Quality Assurance. Addresses product issues or complaints.
  • true
  • false
  • (888) 835-2555
  • -
  • Drug Safety/Adverse Events. To report side-effects and reactions to treatment.
  • true
  • false
  • (800) 821-8590
  • -
  • Medical Communications. Medical information about Genentech products.
  • true
  • false
  • (888) 662-6728
  • Clinical Trial Information Support Line. Please call if you are seeking information about access to one of Genentech's investigational medicines.
  • true
  • false
  • (800) 551-2231
  • -
  • Genentech Customer Service
  • true
  • false

Comments

Hide